A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis. Kim JH, Park S, Jung E, Shin J, et al. Proc Natl Acad Sci U S A 2023;120:e2304081120.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim JH, Park S, Jung E, Shin J, et al. A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasis. Proc Natl Acad Sci U S A 2023;120:e2304081120.
PMID: 37186828